1. Acknowledgement to Referees

   Acknowledgement to Referees 13 November 2013 Pages: 1985 - 1989

2. Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention

   • Amany F. Elbehairy
   • Katherine A. Webb
   • Denis E. O’Donnell

   Current Opinion 09 November 2013 Pages: 1991 - 2001

   

3. Critical Appraisal of Ramucirumab (IMC-1121B) for Cancer Treatment: From Benchside to Clinical Use

   • Giuseppe Aprile
   • Marta Bonotto
   • Francesco Giuliani

   Leading Article 26 November 2013 Pages: 2003 - 2015

   

4. Promoting Remyelination in Multiple Sclerosis—Recent Advances

   • E. Jolanda Münzel
   • Anna Williams

   Review Article Open access 16 November 2013 Pages: 2017 - 2029

   

5. Crizotinib: A Review of Its Use in the Treatment of Anaplastic Lymphoma Kinase-Positive, Advanced Non-Small Cell Lung Cancer

   • James E. Frampton

   Adis Drug Evaluation 28 November 2013 Pages: 2031 - 2051

6. Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome

   • Gillian M. Keating

   Adis Drug Evaluation 19 November 2013 Pages: 2053 - 2066

   

7. Modified-Release Prednisone: in Patients with Rheumatoid Arthritis

   • Sheridan Henness
   • Lily P. H. Yang

   Adis Drug Evaluation 19 November 2013 Pages: 2067 - 2076

8. Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer

   • Sheridan M. Hoy

   Adis Drug Evaluation 23 November 2013 Pages: 2077 - 2091

   

9. Simeprevir: First Global Approval

   • Asha Vaidya
   • Caroline M. Perry

   R&D Insight Report 30 November 2013 Pages: 2093 - 2106